Congenital Anomaly Of Brain: Disease Bioinformatics
There are a large number of congenital anomalies that involve the cranium and the brain and occur as a result of disorders that are present before or at birth. The anomalies stem from developmental issues of the nervous system, and they typically lead to debilitating disorders as well as death in some cases. There is not a single factor which causes brain and cranium anomalies, but can be the effect of genetic conditions, medicines taken during pregnancy, maternal infection, or radiation. An example of congenital brain and cranium anomalies includes anencephaly, where the cephalic end of the neural tube doesn’t close, which results in the baby being born without a forebrain and is blind, deaf and unconsciousness, and has a very small chance of ever waking up. Other common congenital brain and cranium anomalies are colpocephaly, holoprosencephaly, hydranencephaly, iniencephaly, lissencephaly, megalencephaly, microcephaly, porencephaly and schizencephaly.
Congenital Anomaly Of Brain Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Congenital Anomaly Of Brain below!
For more information on how to use Laverne, please read the How to Guide.
We have 488 products for the study of Congenital Anomaly Of Brain that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Congenital Anomaly Of Brain is also known as Brain Malformation, Brain Malformations, Congenital Brain Anomaly, Deformity Of Brain.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.